Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$760,590
-$456,790 QoQ
Shares Held
31,586
-27.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,484
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Inscription Capital, LLC holds $24,225,985 across 10 Drug Manufacturers - General names. PFE ranks #5 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,836 | $7,577,448 | |
| 2 | ABBV |
AbbVie Inc.
|
20,373 | $5,126,661 | |
| 3 | LLY |
ELI LILLY & Co
|
4,139 | $4,964,441 | |
| 4 | MRK |
Merck & Co., Inc.
|
26,514 | $3,407,049 | |
| 5 | PFE |
Pfizer Inc
This page
|
31,586 | $760,590 | |
| 6 | AMGN |
Amgen Inc
|
1,749 | $633,347 | |
| 7 | NVS |
Novartis AG
|
3,412 | $534,728 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,910 | $493,989 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $760,590 | 31,586 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,217,380 | 43,354 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,281,403 | 51,462 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $1,280,268 | 50,246 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $516,312 | 21,300 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $967,582 | 38,184 | Shares | Sole | 2025-04-17 | |
| 2024-09-30 | $926,456 | 32,013 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,018,360 | 36,396 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,059,606 | 38,184 | Shares | Sole | 2024-07-17 | |
| 2023-12-31 | $469,536 | 16,309 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $477,482 | 14,395 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $562,414 | 15,333 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $620,078 | 15,198 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,021,828 | 19,942 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $859,533 | 19,642 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,332,400 | 44,486 | Shares | Sole | 2022-09-20 | |
| 2022-03-31 | $991,499 | 19,152 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,142,735 | 19,352 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $492,120 | 11,442 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $16,195,674 | 413,577 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $419,760 | 11,586 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $282,663 | 7,679 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $272,423 | 7,423 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $212,910 | 6,523 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||